Study medicine will be given alone, or in combination with either sibutramine or orlistat, to obese subjects to compare the effect on body weight over a six month period...
Date First Received: September 19, 2007
Last Updated: September 19, 2007
Verified by: Merck, September 2007
Clinical Trial Phase: Phase 2 | Start Date: December 2003
Overall Status: Completed
Brief Summary
Condition Keyword(s):
Intervention(s):
Study medicine will be given alone, or in combination with either sibutramine or orlistat, to obese subjects to compare the effect on body weight over a six month period.
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Safety/Efficacy Study
Intervention(s) in this Clinical Trial
- Drug: MK0557
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Men and women between the ages of 18-65 who are considered obese (have a body mass index between 30 and 43)
Exclusion Criteria:
- Subject has high blood pressure or is taking any high blood pressure medicine
- History of psychiatric disorder, stroke, or heart disease
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 65 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Merck
Overall Clinical Trial Officials and Contacts
Medical Monitor Study Director Merck
Additional Information
Information obtained from ClinicalTrials.gov on September 05, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00533481
Study ID Number: 2007_615
ClinicalTrials.gov Identifier: NCT00533481
Health Authority: United States: Food and Drug Administration
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
